Acute effects of the cannabinoid receptor agonist WIN55212-2 on dopamine release in rat: An in vivo electrochemical study

Chinese Journal of Physiology

Volumn 51, Issue 3, 2008, Pages 152-159

  Wu, Wun Chin ^a   Wang, Yu ^b   Chai, Chok Yung ^c  

^a NATIONAL PENGHU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cannabinoid receptor; Dopamine; Striatum

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST; POTASSIUM CHLORIDE; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ELECTROCHEMISTRY; EVOKED RESPONSE; IN VIVO STUDY; MALE; NONHUMAN; POTENTIOMETRY; RAT; RECEPTOR BLOCKING;

EID: 54849432218     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Brain Res. 691: 106-114, 1995.
2. Anderson, J.J., KasK, A.M. and Chase, T.N. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor agonists. Eur. J. Pharmacol. 295: 163-168, 1996.
3. Baumeister, A.A., Hawkins, M.F., Anderson-Moore, L.L., Anticich, T.G., Higgins, T.D. and Griffin, P. Effects of bilateral injection of GABA into the substantia nigra on spontaneous behavior and measures of analgesia. Neuropharmacology 27: 817-821, 1988.
4. 2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur. J. Biochem. 237: 704-711, 1996.
5. Cadogan, A.K., Alexander, S.P.H., Boyd, A.E. and Kendall, D.A. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J. Neurochem. 69: 1131-1137, 1997.
6. Calabresi, P., Pisani, A., Mercuri, N.B. and Bernardi, G. The corticalstriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19: 19-24, 1996.
7. Gerhardt, G.A., Oke, A.F., Nagy, G., Moghaddam, B. and Adams, R.N. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290: 390-395, 1984.
8. s linkage to the CB1 receptor. J. Neurosci. 17: 5327-5333, 1997.
9. 9 dopamine neuronal activity in the rat. NeuroReport 6: 1293-1297, 1995.
10. Herkenham, M., Lynn, A.B., de Costa, B.R. and Richfield, E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547: 267-274, 1991.
11. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. and Rice, K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11: 563-583, 1991.
12. Hollister, L.E. Health aspects of cannabis. Pharmacol. Rev. 38: 1-20, 1986.
13. Howlett, A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35: 607-634, 1995.
14. 1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR141716A. J. Neurochem. 68: 402-409, 1997.
15. Kathmann, M., B., Weber, Zimmer, A. and Schlicker, E. Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice. Br. J. Pharmacol. 132: 1169-1173, 2001.
16. Lévénés, C., Daniel, H., Soubrié, P. and Crépel, F. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebella Purkinje cells. J. Physiol. (Lond) 510: 867-879, 1998.
17. Mackie, K., Lai, Y., Westenbroek, R. and Mitchell, R. Cannabinoid activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15: 6552-6561, 1995.
18. 1 , dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson disease. Exper. Neurol. 148: 265-270, 1997.
19. Miller, A.S. and Walker, J.M. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars recticulata. Eur. J. Pharmacol. 279: 179-185, 1995.
20. 9 -tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations. Pharmacol. Biochem. Behav. 45: 291-298, 1993.
21. Niederhoffer, N. and Szabo, B. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Brit. J. Pharmacol. 126: 457-466, 1999.
22. Ohno-Shosaku, T., Maejima, T. and Kano, M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29: 729-738, 2001.
23. Paxinos, G. and Watson, C. The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
24. Pertwee, R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6: 635-664, 1999.
25. 1 and CB2 receptor. Pharmacol. Ther. 74: 129-180, 1997.
26. Rinaldi-Carmona, M., Barth F., HeauIme, M., Alonso, R., Shire, D., Congy, C., Soubrie, P., Breliere, J.C. and Le Far, G. Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 55: 1941-1947, 1995.
27. Saudo-Pea, M.C. and Walker, J.M. Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat. J. Neurophysiol. 77: 1635-1638, 1997.
28. Shen, M. and Thayer, S.A. The cannabinoid agonist Win55212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res. 783: 77-84, 1998.
29. Shen, M., Piser, T.M., Seybold, V.S. and Thayer, S.A. Cannabinoid receptor agonists inhibit glutamergic synaptic transmission in rat hippocampal culture. J. Neurosci. 16: 4322-4334, 1996.
30. Souilhac, J., Poncelet, M., Rinaldi-Carmona, M., Le Fur, G. and Soubrié, P. Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol. Biochem. Behav. 51: 3-7, 1995.
31. Steffens, M., Engler, C., Zentner, J. and Feuerstein T.J. Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. Br. J. Pharmacol. 141: 1193-1203, 2004.
32. Szabo, B., Wallmichrath, I., Mathonia, P. and Pfreundtner, C. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97: 89-97, 2000.
33. Szabo, B., Müller, T. and Koch, H. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J. Neurochem. 73: 1084-1089, 1999.
34. Tanda, G., Pontieri, F.E. and Di Chiara, G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common 1 opioid receptor mechanism. Science 276: 2048-2050, 1997.
35. Tersigni, T.J. and Rosenberg, H.C. Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars recticulata neurons without affecting responseto iontophoretically-applied GABA. Brain Res. 733: 184-192, 1996.
36. Twitchell, W., Brown, S. and Mackie, K. Cannabinoids inhibit N-and P/ Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78: 43-50, 1997.
37. Vaughan, C.W., Conner, M., Bagley, E.E. and Christie, M.J. Actions of cannabinoids on membraneproperties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol. Pharmacol. 57: 288-295, 2000.
38. Wallmichrath, I. and Szabo, B. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata. Naunyn-Schiedeberg Arch. Pharmacol. 365: 326-334, 2002.
39. Zhang, H., Rosenberg, H.C. and Tietz, E.I. Injection of benzodiazepines but not GABA or muscimol into pars reticulata of substantia nigra suppresses pentylyenetrazol seizures. Brain Res. 488: 73-79, 1989.
40. Zhang, H., Weng, X. and Rosenberg, H.C. Characterization of substantia nigra pars reticulata neurons based on response to iontophoretically applied GABA and flurazepam. Life Sci. 53: 1911-1919, 1993.